Status:
COMPLETED
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Parkinson's Disease
Eligibility:
All Genders
50-75 years
Brief Summary
The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional
Eligibility Criteria
Inclusion
- Key inclusion and exclusion criteria for healthy volunteers will be used
- Males and females aged 50-75
Exclusion
Key Trial Info
Start Date :
June 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00460954
Start Date
June 1 2007
End Date
August 1 2007
Last Update
August 14 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Toronto, Ontario, Canada, M5V 2T3